Capricor Therapeutics, Inc. (CAPR)
USD 12.52
(-5.15%)
USD 12.52
(-5.15%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 25.17 Million | 2.54 Million | 244.89 Thousand | 310.25 Thousand | 1 Million | 1.67 Million |
| Cost of Revenue | 1.06 Million | 694.87 Thousand | 245.69 Thousand | 8.45 Million | 5.14 Million | 12.06 Million |
| Gross Profit | 24.1 Million | 1.85 Million | -799.00 | -8.14 Million | -4.13 Million | -10.39 Million |
| Operating Expenses | 12.8 Million | 32.24 Million | 21.18 Million | 14 Million | 8.73 Million | 16.99 Million |
| Selling, General and Administrative Expenses | 12.36 Million | 10.43 Million | 7.61 Million | 5.54 Million | 3.59 Million | 4.93 Million |
| Research and Development Expenses | 36.44 Million | 21.81 Million | 13.57 Million | 8.45 Million | 5.14 Million | 12.06 Million |
| Other Expenses | 442.36 Thousand | 190.58 Thousand | 548.2 Thousand | - | - | - |
| Cost and Expenses | 49.25 Million | 32.24 Million | 21.18 Million | 14 Million | 8.73 Million | 16.99 Million |
| Operating Income | -24.07 Million | -29.69 Million | -20.93 Million | -13.68 Million | -7.73 Million | -15.32 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | -677.85 | -613.41 Thousand | -176.83 Thousand | -264.02 Thousand | 135.99 Thousand |
| Earnings before Tax | -22.28 Million | -29.01 Million | -20.02 Million | -13.65 Million | -7.64 Million | -15.19 Million |
| Net Income | -22.28 Million | -29.01 Million | -19.4 Million | -13.48 Million | -7.37 Million | -15.19 Million |
| Earnings Per Share Basic | -0.83 | -1.18 | -0.84 | -0.87 | -1.99 | -5.17 |
| Earnings Per Share Diluted | -0.83 | -1.18 | -0.84 | -0.87 | -1.99 | -5.17 |
| Weighted Average Shares Outstanding | 26.77 Million | 24.55 Million | 23.08 Million | 15.57 Million | 3.71 Million | 2.93 Million |
| Weighted Average Shares Outstanding (Diluted) | 26.77 Million | 24.55 Million | 23.08 Million | 15.57 Million | 3.71 Million | 2.94 Million |
| Gross Margin | 0.96 | 0.73 | -0.00 | -26.26 | -4.12 | -6.22 |
| EBIT Margin | -0.91 | -11.84 | -87.00 | -44.23 | -7.79 | -9.17 |
| Profit Margin | -0.89 | -11.38 | -79.25 | -43.45 | -7.34 | -9.09 |
| EBITDA | -23 Million | -29.16 Million | -20.69 Million | -13.54 Million | -7.56 Million | -15.16 Million |
| Earnings Before Tax Margin | -0.96 | -11.65 | -85.50 | -44.13 | -7.70 | -9.17 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 3.97 Million | 4.9 Million | 12.08 Million | 25.17 Million | 6.18 Million | 3.91 Million |
| Cost of Revenue | 356.93 Thousand | 331.4 Thousand | 307.6 Thousand | 1.06 Million | 276.47 Thousand | 248.25 Thousand |
| Gross Profit | 3.61 Million | 4.57 Million | 11.78 Million | 24.1 Million | 5.9 Million | 3.66 Million |
| Operating Expenses | 15.2 Million | 14.84 Million | 12.84 Million | 48.18 Million | 13.05 Million | 11.66 Million |
| Selling, General and Administrative Expenses | 2.9 Million | 3.91 Million | 3.07 Million | - | 3.02 Million | 2.84 Million |
| Research and Development Expenses | 12.3 Million | 10.92 Million | 9.77 Million | - | 10.02 Million | 8.81 Million |
| Other Expenses | -852.47 Thousand | - | - | 67.65 Thousand | - | - |
| Cost and Expenses | 15.56 Million | 15.17 Million | 13.15 Million | 49.25 Million | 13.05 Million | 11.66 Million |
| Operating Income | -11.59 Million | -10.26 Million | -1.06 Million | -24.07 Million | -6.86 Million | -7.74 Million |
| Interest Expense | - | - | -415.37 Million | - | - | - |
| Income Tax Expense | 5.00 | 4.00 | 2.00 | -2.00 | -276.47 Thousand | -502.76 Thousand |
| Earnings before Tax | -10.99 Million | -9.79 Million | -762.08 Thousand | -22.28 Million | -6.39 Million | -7.36 Million |
| Net Income | -10.99 Million | -9.79 Million | -762.08 Thousand | -22.28 Million | -6.39 Million | -7.36 Million |
| Earnings Per Share Basic | -0.35 | -0.31 | -0.02 | - | -0.25 | -0.29 |
| Earnings Per Share Diluted | -0.35 | -0.31 | -0.02 | - | -0.25 | -0.29 |
| Weighted Average Shares Outstanding | 31.84 Million | 31.35 Million | 30.66 Million | 26.77 Million | 25.81 Million | 25.33 Million |
| Weighted Average Shares Outstanding (Diluted) | 31.84 Million | 31.35 Million | 30.66 Million | 26.77 Million | 25.81 Million | 25.33 Million |
| Gross Margin | 0.91 | 0.93 | 0.97 | 0.96 | 0.96 | 0.94 |
| EBIT Margin | -2.83 | -2.02 | -0.06 | - | -1.11 | -2.07 |
| Profit Margin | -2.77 | -2.00 | -0.06 | -0.89 | -1.03 | -1.88 |
| EBITDA | -11.23 Million | -9.93 Million | -755.41 Thousand | - | -6.86 Million | -8.12 Million |
| Earnings Before Tax Margin | -2.92 | -2.09 | -0.09 | -0.96 | -1.11 | -1.98 |
HUMANSOFT
DECCAN
BPL
RAMCOIND
603077
PREMIERPOL